Jennifer Gudeman
Technik-/Wissenschafts-/F&E-Leiter bei AVADEL PHARMACEUTICALS PLC
Aktive Positionen von Jennifer Gudeman
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AVADEL PHARMACEUTICALS PLC | Technik-/Wissenschafts-/F&E-Leiter | 07.12.2020 | - |
Karriereverlauf von Jennifer Gudeman
Ehemalige bekannte Positionen von Jennifer Gudeman
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
AMAG Pharma USA, Inc.
AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharma USA, Inc. engages in the provision of pharmaceutical products to independent pharmacies, managed care organizations, hospitals, pharmacy benefit management companies, government entities, and physicians. The company was founded by Victor M. Hermelin in 1942 and is headquartered in Waltham, MA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2003 | - |
Ausbildung von Jennifer Gudeman
St. Louis College of Pharmacy | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Irland | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 2 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
AVADEL PHARMACEUTICALS PLC | Health Technology |
Private Unternehmen | 2 |
---|---|
AMAG Pharma USA, Inc.
AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharma USA, Inc. engages in the provision of pharmaceutical products to independent pharmacies, managed care organizations, hospitals, pharmacy benefit management companies, government entities, and physicians. The company was founded by Victor M. Hermelin in 1942 and is headquartered in Waltham, MA. | Health Technology |
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Börse
- Insiders
- Jennifer Gudeman
- Erfahrung